Resmed (RMD) debt: $404M
Resmed had $404M of long-term debt on Dec 31, 2025, including the part due within a year, down 39.1% from $663M a year earlier.
From Resmed's filings with the SEC · Read the filing · RMD stock page
Resmed debt by year
#1,194 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 31, 2025 | $404M | -39% |
| Dec 31, 2024 | $663M | -46% |
| Dec 31, 2023 | $1.2B | -32% |
| Dec 31, 2022 | $1.8B | +168% |
| Dec 31, 2021 | $668M | – |
Debt of similar companies
Companies in the same industry as Resmed, by SEC industry code, with the closest debt. Each name opens the same page for that company.
| Company | Debt, latest year | Year ended |
|---|---|---|
| Merit Medical Systems | $734M | Dec 31, 2025 |
| Integra Lifesciences Holdings | $727M | Dec 31, 2025 |
| Alphatec Holdings | $566M | Dec 31, 2025 |
| Resmed | $404M | Dec 31, 2025 |
| Tandem Diabetes Care | $310M | Dec 31, 2025 |
| Bioventus | $294M | Dec 31, 2025 |
| Artivion | $215M | Dec 31, 2025 |
Questions and answers
What is Resmed's debt?
Resmed had $404M of long-term debt on Dec 31, 2025, including the part due within a year, down 39.1% from $663M a year earlier.
Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology